Georgia CaRes

描述（由申请人提供）：自2004年以来，格鲁吉亚摄政大学（GRU）一直是格鲁吉亚唯一的NCI MB-CCOP的所在地。通过其附属网站大学癌症与血液中心（UCBC），GRU已经招募了近800名患者参加NCI临床试验：其中39%是非洲裔美国人（AA）和其他少数民族，治疗试验（48%）和预防和控制试验（52%）之间的应计费用分配。在这一成功记录的基础上，GRU癌症中心（GRUCC）和UCBC正在与莫尔豪斯医学院（MSM）和格鲁吉亚南方大学的徐建平公共卫生学院（JPHCOPH）联手，成为格鲁吉亚的NCORP少数民族/服务不足社区网站。维持和发展一个以格鲁吉亚少数民族和服务不足人口为重点的NCORP的必要性是巨大的。格鲁吉亚有一些全国最严重的癌症差异，非洲裔美国人（AA）和高加索人（CA）之间以及农村和城市人口之间的特殊性。对于一些最常见的癌症来说，这种差异是显而易见的。格鲁吉亚的AA男性不仅是全国AA男性中前列腺癌发病率最高的，而且他们被诊断出患有这种疾病的可能性几乎是格鲁吉亚CA男性的两倍，死于这种疾病的可能性是三倍。在格鲁吉亚，AA女性死于乳腺癌的几率比CA女性高25%，AA死于结直肠癌的几率比CA高45%。拟议的格鲁吉亚NCORP M/U站点的具体目标是：1）为格鲁吉亚实施一个符合或超过所有NCI要求的NCORP M/U站点; 2）为国家NCORP研究议程的设计、实施和翻译做出贡献，涉及少数民族和服务不足人群的特殊性研究;和3）在整个格鲁吉亚扩大患者和提供者对癌症预防、控制、成像、治疗和筛查/后监测临床试验和癌症护理提供研究的访问和登记/参与，特别是对城市和农村地区的少数群体和得不到充分服务的人口而言。关键的次级目标包括实施领导力发展计划，以培养下一代NCORP调查人员和领导者，并在NCORP研究议程的各个方面与关键利益相关者和社区合作伙伴进行接触。

DESCRIPTION (provided by applicant): Georgia Regents University (GRU) has been home to Georgia's only NCI MB-CCOP since 2004. With its affiliate site, University Cancer & Blood Center (UCBC), GRU has enrolled nearly 800 patients to NCI clinical trials: 39% of them African American (AA) and other minorities, with accrual split between treatment trials (48%) and prevention and control trials (52%). Building on this successful track record, GRU Cancer Center (GRUCC) and UCBC are joining forces with Morehouse School of Medicine (MSM) and the Jiann-Ping Hsu College of Public Health (JPHCOPH) at Georgia Southern University to become the NCORP Minority/Underserved Community Site for Georgia. The need to sustain and grow an NCORP that focuses on minority and underserved populations in Georgia is great. Georgia has some of the nation's worst cancer disparities, particularity between African Americans (AA) and Caucasians (CA) and between rural and urban populations. The disparities are glaring for some of the most common cancers. Not only do AA men in Georgia have the highest rate of prostate cancer among AA men in the country, they are almost twice as likely to be diagnosed with the disease as CA men in Georgia and three times as likely to die from it. In Georgia, AA women die of breast cancer 25% more often than CA women, and AA die of colorectal cancer 45% more than CA. The Specific Aims of the proposed NCORP M/U site for Georgia are to: 1) Implement a NCORP M/U Site for Georgia that meets or exceeds all NCI requirements; 2) Contribute to the design, conduct and translation of the national NCORP research agenda, particularity studies that pertain to minority and underserved populations; and 3) expand patient and provider access to-and enrollment/participation in-cancer prevention, control, imaging, treatment and screening/post-surveillance clinical trials and cancer care delivery research throughout Georgia, particularly for minority and underserved populations in urban and rural settings. Key sub-aims include the implementation of a leadership development program to cultivate the next generation of NCORP investigators and leaders and engagement to key stakeholders and community partners in all aspects of the NCORP research agenda.